Publications by authors named "S Boguslawski"
Article Synopsis
- The study aimed to investigate the long-term lung effects of COVID-19 pneumonia in children aged 0-18, focusing on follow-up assessments three and six months after hospitalization.
- Among 41 participants, around 17% reported lingering symptoms like decreased exercise tolerance, dyspnea, and cough, while lung ultrasound highlighted abnormalities that were more pronounced initially but improved by the second visit.
- Despite some persistent symptoms, the pulmonary function tests did not show significant differences compared to healthy children or between follow-up visits, suggesting that long-term impacts may be mild and tend to resolve.
Background: Data on the prevalence and type of lung function impairment in preschool and school-aged children previously diagnosed with persistent tachypnea of infancy (PTI) are scarce. Therefore, this study aims to assess pulmonary function in this age group.
Methods: Children diagnosed with PTI over 3 years old were admitted for follow-up visits and healthy controls were enrolled.
Objective: The aim of the study is to compare rates of prenatal care utilization before and after implementation of a telehealth-supplemented prenatal care model due to the coronavirus disease 2019 (COVID-19) pandemic.
Study Design: Using electronic medical record data, we identified two cohorts of pregnant persons that initiated prenatal care prior to and during the COVID-19 pandemic following the implementation of telehealth (from March 1, 2019 through August 31, 2019, and from March 1, 2020, through August 31, 2020, respectively) at Grady Memorial Hospital. We used Pearson's Chi-square and two-tailed -tests to compare rates of prenatal care utilization, antenatal screening and immunizations, emergency department and obstetric triage visits, and pregnancy complications for the prepandemic versus pandemic-exposed cohorts.
Background: Clinical guidelines recommend using single pill combinations (SPC) when initiating and intensifying the treatment of arterial hypertension (AH), which is not reflected in the Summaries of Product Characteristics (SMPC) for individual preparations. The drug reimbursement system in Poland (with a few exceptions) does not provide for reimbursement outside the indications specified in the SMPC. Therefore, it excludes the use of SPC under reimbursement.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to evaluate how well Polish physicians follow guidelines for diagnosing and managing cow's milk allergy (CMA) in children.
- Only 27.4% of surveyed physicians performed oral food challenges (OFC) to confirm CMA, with most using open challenges despite recommendations.
- While 79.2% indicated that extensively hydrolyzed cow's milk formula is the first-line treatment for mild-to-moderate CMA, less than half recommended the appropriate treatment for severe cases and only about half reassessed children's tolerance to cow's milk proteins.